Association of Non High Density Lipoprotein-Cholesterol and HbA1c in Type 2 Diabetes Mellitus
Background: Dyslipidemia is a common issue among diabetic patients and is associated with an increased risk of cardiovascular disease. Non-High Density Lipoprotein-cholesterol has emerged as a valuable marker for assessing combined cardiovascular risk in diabetes. Measures to improve the Non-High De...
Main Authors: | Saroj Thapa, Nirish Vaidya, Rachana Pandey, Jyoti Shrestha Takanche |
---|---|
Format: | Article |
Language: | English |
Published: |
Nobel Medical College Teaching Hospital
2023-12-01
|
Series: | Journal of Nobel Medical College |
Subjects: | |
Online Access: | https://www.nepjol.info/index.php/JoNMC/article/view/61111 |
Similar Items
-
The association between glycemic control and non-high density lipoprotein cholesterol in type 2 diabetic patients
by: Pratik Gajanan Phadake, et al.
Published: (2019-01-01) -
GLYCATED HEMOGLOBIN AS A BIOMARKER TO PREDICT DYSLIPIDEMIA IN TYPE 2 DIABETES MELLITUS
by: Abdul Moueed Tariq, et al.
Published: (2020-10-01) -
GLYCATED HEMOGLOBIN AS A BIOMARKER TO PREDICT DYSLIPIDEMIA IN TYPE 2 DIABETES MELLITUS
by: Abdul Moueed Tariq, et al.
Published: (2020-10-01) -
Drugs affecting HbA1c levels
by: Ranjit Unnikrishnan, et al.
Published: (2012-01-01) -
Association between glycated hemoglobin (HbA1c) and the lipid profile in patients with type 2 diabetes mellitus at a tertiary care hospital: a retrospective study
by: Alzahrani SH, et al.
Published: (2019-08-01)